Search hospitals > Pennsylvania > Lancaster
Lancaster General Hospital
Claim this profileLancaster, Pennsylvania 17601
Global Leader in Breast Cancer
Global Leader in Heart Failure
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
169 reported clinical trials
17 medical researchers
Summary
Lancaster General Hospital is a medical facility located in Lancaster, Pennsylvania. This center is recognized for care of Breast Cancer, Heart Failure, Cancer, Lung Cancer, Adenocarcinoma and other specialties. Lancaster General Hospital is involved with conducting 169 clinical trials across 224 conditions. There are 17 research doctors associated with this hospital, such as Sandeep Bansal, Caitlin S. Farabaugh, Pamela Boimel, and Ami P. Jhaveri.Area of expertise
1Breast Cancer
Global LeaderStage II
ER positive
HER2 negative
2Heart Failure
Global LeaderTop PIs
Sandeep BansalGSK Investigational Site1 year of reported clinical research
Studies Asthma
Studies Chronic Obstructive Pulmonary Disease
16 reported clinical trials
21 drugs studied
Caitlin S. FarabaughLancaster General Ann B Barshinger Cancer Institute7 years of reported clinical research
Studies Endometrioid Carcinoma
Studies Endometrial Cancer
4 reported clinical trials
10 drugs studied
Pamela BoimelLancaster General Hospital5 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
3 reported clinical trials
9 drugs studied
Ami P. JhaveriLancaster General Hospital4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
2 reported clinical trials
4 drugs studied
Clinical Trials running at Lancaster General Hospital
Breast Cancer
Ovarian Cancer
Heart Failure
Obesity
Cardiovascular Disease
Squamous Cell Carcinoma
Non-Hodgkin's Lymphoma
Deep Vein Thrombosis
Ventricular Tachycardia
Cardiomyopathy
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Lancaster General Hospital?
Lancaster General Hospital is a medical facility located in Lancaster, Pennsylvania. This center is recognized for care of Breast Cancer, Heart Failure, Cancer, Lung Cancer, Adenocarcinoma and other specialties. Lancaster General Hospital is involved with conducting 169 clinical trials across 224 conditions. There are 17 research doctors associated with this hospital, such as Sandeep Bansal, Caitlin S. Farabaugh, Pamela Boimel, and Ami P. Jhaveri.